UBS Group’s Molina Healthcare MOH Stock Holding History

UBS Group’s Portfolio MOH Stock Details MOH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,800	Closed	-$2.34M	–	10227
2024 Q3	$2.34M	Buy	+6,800	New	+$2.24M	﹤0.01%	3841

Other funds holding MOH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS Group's MOH Position: Q2 2026 in Review

UBS Group increased its Molina Healthcare (MOH) stake by 32% in Q2 2026, buying an estimated $27.5M and bringing the position to 624,180 shares worth $143M. The position accounts for 0.02% of the portfolio, ranked #890.

UBS Group first reported a position in MOH in Q4 2014 and has held it in 47 quarters since. 602 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

UBS Group held 624,180 shares of Molina Healthcare worth $143M as of Q2 2026.
UBS Group bought 151,704 Molina Healthcare shares in Q2 2026, an estimated $27.5M.
Molina Healthcare made up 0.02% of UBS Group's portfolio in Q2 2026, its #890 holding.
UBS Group first reported a position in Molina Healthcare in Q4 2014 and has held it in 47 quarters since.
602 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.